BDBM639349 2-(1-Methyl-1H-imidazol-2-yl)ethyl 3-[(5-chlorothiophene-2-carbonyl)amino]-N-{2-ethyl-3-[(3S)-3-hydroxy-2-oxopyrrolidin-1-yl]benzene-1-sulfonyl}-S-alaninate::US20230391761, Example 1::US20230391761, Example 2::US20230391761, Example 3::US20230391761, Example 5::US20230391761, Example 6::US20230391761, Example 7::US20230391761, Example 8::US20230391761, Example 9

SMILES CCc1c(cccc1S(=O)(=O)N[C@@H](CNC(=O)c1ccc(Cl)s1)C(=O)OCCc1nccn1C)N1CC[C@H](O)C1=O

InChI Key InChIKey=UHRIYOJEACOYON-UHFFFAOYSA-N

Data  36 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 36 hits for monomerid = 639349   

TargetCytochrome P450 1A2(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 2.00E+4nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetProthrombin(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 4.5nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 0.560nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetProthrombin(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 5.20nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 0.850nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetProthrombin(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 6nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 0.490nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetProthrombin(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 4.60nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 1.49E+4nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 0.510nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetCytochrome P450 2C8(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 2.00E+4nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetCytochrome P450 2C9(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 2.00E+4nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetCytochrome P450 2D6(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 2.00E+4nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 1.85E+4nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetCytochrome P450 1A2(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 2.00E+4nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetCytochrome P450 2C8(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 2.00E+4nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetCytochrome P450 2C9(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 2.00E+4nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetCytochrome P450 2D6(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 2.00E+4nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetCoagulation factor XI(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 3.10E+4nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetProthrombin(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 5.30nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetCoagulation factor XI(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 3.60E+4nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetSerine protease 1(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 3.20E+3nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetPlasminogen(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 1.60E+4nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetTissue-type plasminogen activator(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 7.40E+3nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetKallikrein-1(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 420nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 0.660nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetProthrombin(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 4.90nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 0.710nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetSerine protease 1(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 2.70E+3nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetPlasminogen(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 1.50E+4nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetTissue-type plasminogen activator(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 6.50E+3nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetKallikrein-1(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 380nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 0.780nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetProthrombin(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 5.90nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 0.780nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent

TargetProthrombin(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM639349(US20230391761, Example 2 | 2-(1-Methyl-1H-imidazol...)
Affinity DataIC50: 5.80nMAssay Description:Determination of the Selectivity To demonstrate the selectivity of the substances with respect to thrombin and factor Xa inhibition, the test substan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2024
Entry Details
Go to US Patent